These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 7665979)

  • 1. Enhancement of erythropoietin production by selective adenosine A2 receptor agonists in response to hypoxia.
    Ohigashi T; Nakashima J; Aggarwal S; Brookins J; Agrawal K; Fisher JW
    J Lab Clin Med; 1995 Sep; 126(3):299-306. PubMed ID: 7665979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenosine A1 receptors and erythropoietin production.
    Ohigashi T; Brookins J; Fisher JW
    Am J Physiol; 1993 Oct; 265(4 Pt 1):C934-8. PubMed ID: 8238318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of 5'-N-ethylcarboxamideadenosine (NECA) on erythropoietin production.
    Nakashima J; Ohigashi T; Brookins JW; Beckman BS; Agrawal KC; Fisher JW
    Kidney Int; 1993 Oct; 44(4):734-40. PubMed ID: 8258950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenosine A(2A) and A(2B) receptor activation of erythropoietin production.
    Fisher JW; Brookins J
    Am J Physiol Renal Physiol; 2001 Nov; 281(5):F826-32. PubMed ID: 11592940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of erythropoietin production by selective adenosine agonists and antagonists in normal and anemic rats.
    Nagashima K; Karasawa A
    Life Sci; 1996; 59(9):761-71. PubMed ID: 8761029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A1 and A2 adenosine receptor regulation of erythropoietin production.
    Ueno M; Brookins J; Beckman B; Fisher JW
    Life Sci; 1988; 43(3):229-37. PubMed ID: 3398696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [3H]CGS 21680, a selective A2 adenosine receptor agonist directly labels A2 receptors in rat brain.
    Jarvis MF; Schulz R; Hutchison AJ; Do UH; Sills MA; Williams M
    J Pharmacol Exp Ther; 1989 Dec; 251(3):888-93. PubMed ID: 2600819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding characteristics of the adenosine A2 receptor ligand [3H]CGS 21680 to human platelet membranes.
    Varani K; Borea PA; Guerra L; Dionisotti S; Zocchi C; Ongini E
    Biochem Pharmacol; 1994 Oct; 48(8):1658-61. PubMed ID: 7980632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Increase in erythropoietin secretion mediated by adenosine A2 receptors].
    Nakashima J; Tazaki H; Fisher JW
    Hum Cell; 1993 Mar; 6(1):36-41. PubMed ID: 8393698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenosine A2 receptor modulation of erythropoietin secretion in hepatocellular carcinoma cells.
    Nakashima J; Brookins J; Ohigashi T; Fisher JW
    Life Sci; 1994; 54(2):109-17. PubMed ID: 8123156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular effects of adenosine A2 agonists in the conscious spontaneously hypertensive rat: a comparative study of three structurally distinct ligands.
    Webb RL; Barclay BW; Graybill SC
    J Pharmacol Exp Ther; 1991 Dec; 259(3):1203-12. PubMed ID: 1684818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacology of the spinal adenosine receptor which mediates the antiallodynic action of intrathecal adenosine agonists.
    Lee YW; Yaksh TL
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1642-8. PubMed ID: 8667233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence against a major role of adenosine in oxygen-dependent regulation of erythropoietin in rats.
    Gleiter CH; Brause M; Delabar U; Zebski H; Eckardt KU
    Kidney Int; 1997 Aug; 52(2):338-44. PubMed ID: 9263988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia upregulates glucose transport activity through an adenosine-mediated increase of GLUT1 expression in retinal capillary endothelial cells.
    Takagi H; King GL; Aiello LP
    Diabetes; 1998 Sep; 47(9):1480-8. PubMed ID: 9726238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of adenosine receptors in human erythroleukemia cells and platelets: further evidence for heterogeneity of adenosine A2 receptor subtypes.
    Feoktistov I; Biaggioni I
    Mol Pharmacol; 1993 Jun; 43(6):909-14. PubMed ID: 8391117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of biochemical effects of CGS 21680C, an A2-adenosine receptor agonist, in the mammalian ventricle.
    Bokník P; Neumann J; Schmitz W; Scholz H; Wenzlaff H
    J Cardiovasc Pharmacol; 1997 Dec; 30(6):750-8. PubMed ID: 9436814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of erythropoietin production in a hepatocellular carcinoma cell line.
    Nakashima J; Brookins J; Fisher JW
    J Lab Clin Med; 1992 Mar; 119(3):306-14. PubMed ID: 1311742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of nitric oxide and cyclic guanosine 3',5'-monophosphate in erythropoietin production.
    Ohigashi T; Brookins J; Fisher JW
    J Clin Invest; 1993 Sep; 92(3):1587-91. PubMed ID: 8397229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repeated administration of selective adenosine A1 and A2 receptor agonists in the spontaneously hypertensive rat: tolerance develops to A1-mediated hemodynamic effects.
    Casati C; Monopoli A; Dionisotti S; Zocchi C; Bonizzoni E; Ongini E
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1506-11. PubMed ID: 8138961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inducible nitric oxide synthase expression and erythropoietin production in human hepatocellular carcinoma cells.
    Yoshioka K; Thompson J; Miller MJ; Fisher JW
    Biochem Biophys Res Commun; 1997 Mar; 232(3):702-6. PubMed ID: 9126339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.